Skip to Content

Brentuximab Vedotin



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Therapeutic Category

Antineoplastic agent

Chemical Name

Immunoglobulin G1-kappa auristatin E conjugate, anti-[Homo sapiensTNFRSF8 (tumor necrosis factor receptor superfamily member 8, KI-1, CD30)], chimeric monoclonal antibody conjugated to auristatin E; gamma1 heavy chain (1-446) [Mus musculusVH (IGHV1-84*02- (WHO )

Foreign Names

  • Brentuximabum Vedotinum (Latin)
  • Brentuximab Vedotin (German)
  • Brentuximab VĂ©dotine (French)
  • Brentuximab Vedotina (Spanish)

Generic Names

  • Brentuximab Vedotin (OS: USAN, BAN)
  • Brentuximab Vedotin (Genetical Recombination) (OS: JAN)
  • antibody-drug conjugate SGN-35 (IS)
  • anti-CD30 ADC SGN-35 (IS)
  • anti-CD30 antibody-drug conjugate SGN-35 (IS)
  • cAC10-vcMMAE (IS)
  • SGN-35 (IS)
  • UNII-7XL5ISS668 (IS)

Brand Names

  • Adcetris
    Seattle Genetics, Inc., United States; Takeda, Bosnia & Herzegowina; Takeda, Belgium; Takeda, Germany; Takeda, Spain; Takeda, Finland; Takeda, Hong Kong; Takeda, Croatia (Hrvatska); Takeda, Hungary; Takeda, Ireland; Takeda, Israel; Takeda, Italy; Takeda, Latvia; Takeda, Norway; Takeda, Poland; Takeda, Singapore; Takeda France, France; Takeda Pharma, Switzerland; Takeda Pharma, Denmark; Takeda Pharma, Sweden; Takeda Pharmaceutical, Japan; Takeda UK, United Kingdom


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.